Customer concentration through a key distributor
One just-in-time distributor represented 10% or more of consolidated revenue, so loss or disruption would materially reduce sales.
- Scope
- Distributor channel
- Materiality
- high
Masimo Corp
Masimo Corp develops and markets noninvasive patient monitoring technologies, hospital automation and connectivity solutions, and remote monitoring devices for healthcare settings. The company sells through direct sales, distributors, and OEM partners, with products used to measure patient status in hospitals, EMS, home care, physician offices, veterinary, and long-term care settings.
22,8 %
61,9 %
−9,9 %
2.49
1.47
| % | |
|---|---|
| Patient monitoring systems | 45% Core hospital and clinical monitoring platforms used to track patient status noninvasively. |
| Sensors and consumables | 30% Single-patient-use and reusable sensors and related consumables used with monitoring devices. |
| Hospital automation and connectivity | 10% Workflow, connectivity, and integration solutions for hospital environments. |
| Remote monitoring and home care | 8% Devices and solutions used outside acute care, including home care and long-term care. |
| OEM and partner channel products | 7% Monitoring technologies sold through OEM partners and distributor relationships. |
Masimo sells primarily to healthcare providers and channel partners that need reliable patient monitoring and workflow...
- Hospitals and health systemsprimary
Buy monitoring platforms, sensors, and connectivity tools to support bedside care and workflow efficiency.
- OEM partnersprimary
Integrate Masimo technology into third-party devices and platforms to broaden market access.
- Distributors and just-in-time distributorsprimary
Purchase and resell products, including tender-driven and international orders, to extend commercial reach.
- EMS, home care, and long-term care providerssecondary
Buy remote and portable monitoring solutions for non-acute and mobile care settings.
- Physician offices and veterinarianssecondary
Purchase point-of-care monitoring products for smaller clinical and specialty-use settings.
Masimo is described as a global technology company, and its revenue includes foreign sales denominated in various...
- •Global sales footprint with direct, distributor, and OEM channels
- •Foreign sales are exposed to currency translation effects
- •Material components and sub-assemblies are sourced from Mexico, China, and Malaysia
- •International tenders and distributors are important to growth
- •U.S. trade policy and tariffs can affect both supply chain and pricing
Masimo is focused on innovation in noninvasive monitoring, hospital automation, and remote care while using direct,...
01
Product innovation in monitoring and remote caremedium-term
Differentiated technology supports pricing power, clinical adoption, and long-term customer retention.
02
Channel expansion through OEMs and distributorsshort-term
Broader partner coverage increases market access and helps win large tenders and international accounts.
03
Infrastructure and capital investmentmedium-term
Capacity, systems, and operational infrastructure support growth and product commercialization.
04
Protect intellectual propertylong-term
IP protection helps defend technology differentiation and supports long-term monetization.
Masimo faces customer concentration risk, especially through a just-in-time distributor that represented 10% or more of...
Tariffs and trade policy changes
Material components and sub-assemblies are sourced or manufactured outside the U.S., making costs and supply availability sensitive to trade actions.
- Scope
- Mexico, China, Malaysia sourcing
- Materiality
- high
Foreign exchange volatility
Foreign sales denominated in various currencies can translate into lower U.S. dollar revenue when exchange rates move unfavorably.
- Scope
- International sales
- Materiality
- medium
Regulatory and policy changes in healthcare
Changes in funding, staffing, trade, or regulatory policy can affect customer purchasing and product commercialization.
- Scope
- U.S. healthcare market
- Materiality
- medium
IP litigation and defense costs
The company expects continued legal defense of intellectual property, which can be costly and uncertain.
- Scope
- Patent and trademark portfolio
- Materiality
- medium
Revenue recognition timing
Quarterly comparability and reported growth rates
Inventory valuation
Gross profit and cost of goods sold
Goodwill and intangible assets
Non-cash impairment charges and balance sheet values
Discontinued operations
Comparability of revenue, profit, and cash flow trends
Stock-based compensation and tax contingencies
SG&A, tax provision, and net income
: 28.4.2026